Pro Share Advisors LLC Vertex Pharmaceuticals Inc Transaction History

Pro Share Advisors LLC

  • $42.5 Billion
  • Q4 2024

A detailed history of Pro Share Advisors LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Pro Share Advisors LLC holds 344,526 shares of VRTX stock, worth $163 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
344,526
Previous 291,410 18.23%
Holding current value
$163 Million
Previous $136 Million 2.37%
% of portfolio
0.33%
Previous 0.34%

Shares

31 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 13, 2025
BUY
$396.64 - $516.74 $21.1 Million - $27.4 Million
53,116 Added 18.23%
344,526 $139 Million
Q3 2024

Nov 13, 2024
BUY
$460.0 - $505.78 $9.97 Million - $11 Million
21,669 Added 8.03%
291,410 $136 Million
Q2 2024

Aug 13, 2024
SELL
$392.81 - $485.53 $12 Million - $14.8 Million
-30,529 Reduced 10.17%
269,741 $126 Million
Q1 2024

May 08, 2024
BUY
$407.69 - $446.08 $19.9 Million - $21.7 Million
48,699 Added 19.36%
300,270 $126 Million
Q4 2023

Feb 14, 2024
SELL
$343.0 - $410.68 $15.5 Million - $18.6 Million
-45,253 Reduced 15.25%
251,571 $102 Million
Q3 2023

Nov 13, 2023
BUY
$338.18 - $362.46 $11.9 Million - $12.8 Million
35,214 Added 13.46%
296,824 $103 Million
Q2 2023

Aug 10, 2023
SELL
$314.42 - $351.91 $5.81 Million - $6.51 Million
-18,485 Reduced 6.6%
261,610 $92.1 Million
Q1 2023

May 11, 2023
BUY
$283.23 - $323.1 $7.03 Million - $8.02 Million
24,813 Added 9.72%
280,095 $88.2 Million
Q4 2022

Feb 02, 2023
SELL
$285.76 - $321.48 $7.55 Million - $8.5 Million
-26,430 Reduced 9.38%
255,282 $73.7 Million
Q3 2022

Nov 04, 2022
SELL
$273.83 - $305.53 $13.3 Million - $14.9 Million
-48,614 Reduced 14.72%
281,712 $81.6 Million
Q2 2022

Aug 01, 2022
SELL
$234.96 - $292.55 $37.3 Million - $46.4 Million
-158,650 Reduced 32.45%
330,326 $93.1 Million
Q1 2022

May 10, 2022
SELL
$221.42 - $260.97 $6.25 Million - $7.36 Million
-28,213 Reduced 5.46%
488,976 $128 Million
Q4 2021

Feb 08, 2022
BUY
$177.01 - $223.45 $25.5 Million - $32.2 Million
144,037 Added 38.6%
517,189 $114 Million
Q3 2021

Nov 12, 2021
BUY
$181.39 - $202.99 $6.08 Million - $6.8 Million
33,518 Added 9.87%
373,152 $67.7 Million
Q2 2021

Aug 13, 2021
SELL
$187.49 - $221.1 $950,386 - $1.12 Million
-5,069 Reduced 1.47%
339,634 $68.5 Million
Q1 2021

May 14, 2021
BUY
$207.02 - $241.31 $9.31 Million - $10.9 Million
44,967 Added 15.0%
344,703 $74.1 Million
Q4 2020

Feb 09, 2021
BUY
$207.01 - $276.09 $7.67 Million - $10.2 Million
37,064 Added 14.11%
299,736 $70.8 Million
Q3 2020

Nov 13, 2020
BUY
$255.65 - $303.1 $8.91 Million - $10.6 Million
34,849 Added 15.3%
262,672 $71.5 Million
Q2 2020

Aug 03, 2020
BUY
$225.48 - $295.8 $6.16 Million - $8.08 Million
27,309 Added 13.62%
227,823 $66.1 Million
Q1 2020

May 15, 2020
SELL
$199.77 - $247.81 $17.1 Million - $21.2 Million
-85,641 Reduced 29.93%
200,514 $47.7 Million
Q4 2019

Feb 12, 2020
BUY
$166.71 - $223.91 $2.26 Million - $3.03 Million
13,551 Added 4.97%
286,155 $62.7 Million
Q3 2019

Nov 12, 2019
BUY
$166.23 - $187.09 $771,639 - $868,471
4,642 Added 1.73%
272,604 $46.2 Million
Q2 2019

Aug 13, 2019
SELL
$164.61 - $190.37 $4.72 Million - $5.45 Million
-28,653 Reduced 9.66%
267,962 $49.1 Million
Q1 2019

May 15, 2019
BUY
$163.73 - $194.7 $4.46 Million - $5.3 Million
27,238 Added 10.11%
296,615 $54.6 Million
Q4 2018

Feb 14, 2019
BUY
$151.91 - $192.21 $4.01 Million - $5.07 Million
26,403 Added 10.87%
269,377 $44.6 Million
Q3 2018

Nov 14, 2018
SELL
$167.73 - $192.74 $4.22 Million - $4.85 Million
-25,163 Reduced 9.38%
242,974 $46.8 Million
Q2 2018

Aug 13, 2018
SELL
$145.72 - $169.96 $6.93 Million - $8.08 Million
-47,540 Reduced 15.06%
268,137 $45.6 Million
Q1 2018

May 14, 2018
BUY
$151.6 - $177.13 $5.74 Million - $6.7 Million
37,852 Added 13.62%
315,677 $51.4 Million
Q4 2017

Feb 14, 2018
BUY
$137.28 - $155.55 $8.31 Million - $9.41 Million
60,520 Added 27.85%
277,825 $41.6 Million
Q3 2017

Nov 13, 2017
BUY
$148.13 - $162.24 $2.26 Million - $2.47 Million
15,247 Added 7.55%
217,305 $33 Million
Q2 2017

Aug 11, 2017
BUY
N/A
202,058
202,058 $26 Million

Others Institutions Holding VRTX

# of Institutions
1,753
Shares Held
227M
Call Options Held
1.63M
Put Options Held
1.47M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $122B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Pro Share Advisors LLC Portfolio

Follow Pro Share Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pro Share Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pro Share Advisors LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email